# OnCo record orient-16 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/orient-16/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "orient-16", "NCT03745170" ;
  schema:name "ORIENT-16"@en ;
  schema:description "The Chinese stomach cancer trial that showed adding sintilimab to chemotherapy helps patients live longer, especially when the tumour expresses PD-L1."@en ;
  schema:url <https://onco.cc/trials/orient-16/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03745170>, <https://doi.org/10.1001/jama.2023.19918> ;
  onco:status "positive" ;
  onco:tag "china" ;
  onco:phase "3" ;
  schema:startDate "2018-12-19" ;
  onco:cancers <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/sintilimab/>, <https://onco.cc/drugs/oxaliplatin/> ;
  onco:companies <https://onco.cc/companies/innovent/> ;
  onco:terms <https://onco.cc/terms/cps/> ;
  onco:people <https://onco.cc/people/xu-jianming/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-xu-jama/> .